Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022
Consolidate Net Profit
YoY Growth in quarter ended Sep 2023 is 59.48% vs 9.20% in Sep 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2023 is 62.77% vs 13.56% in Sep 2022
Interest
YoY Growth in quarter ended Sep 2023 is 50.00% vs -20.00% in Sep 2022
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022
Compare Quarterly Results Of Evelo Biosciences, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2023 is 41.23% vs 16.60% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 59.48% vs 9.20% in Sep 2022
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2023 is 37.42% vs 31.22% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 62.77% vs 13.56% in Sep 2022
Quarterly - Interest
QoQ Growth in quarter ended Sep 2023 is -14.29% vs 27.27% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 50.00% vs -20.00% in Sep 2022






